Last Updated on October 10, 2024 by The Health Master
The Indian Pharmacopoeia Commission (IPC) and United States Pharmacopoeia (USP) India recently held discussions in Hyderabad on areas of mutual cooperation for setting drug standards and development of reference standards.
Ghaziabad-based IPC provides Indian Pharmacopoeia Reference Substances (IPRS) which act as a fingerprint for the identification of an article under test and its purity as prescribed in Indian Pharmacopoeia (IP).
To read more articles about IPC, Click here
“During the meet, both IPC and USP India presented their current activities and evolving plans particularly with respect to C-19 and impurities. Discussions were also held on the renewal of the Memorandum of Understanding (MoU) between IPC and USP as per current evolving needs.
The meet was also a relevant step towards capacity building, training, networking, knowledge-sharing, and enhancing compliance through organizing training programs and seminars,” informed Dr. Rajeev Singh Raghuvanshi, secretary-cum-scientific director, IPC.
The discussions were also aimed at making timely policy interventions and regulatory initiatives towards accessibility and quality of medicines to help tackle the C-19 pandemic on a war footing.
Also read:
Good storage practice of Medicines at Medical Store
Remdesivir should be supplied only to hospitals: NITI Aayog
Cipla doubles Remdesivir production to meet demand
FICCI recommends PLI-like scheme to ramp-up vaccine production
Black marketing of Remdesivir: DCGI again sounds alert to SLAs
AIOCD asks all its members not to indulge in hoarding of…
The IPC in the recent past has also signed an MoU with the British Pharmacopoeia Commission (BPC) for knowledge sharing on pharmacopoeial standards.
Through this MoU, both the institutions will recognize the importance of developing close cooperation and exchange of information in the field of regulation of medicines with special reference to pharmacopoeial standards in accordance with their respective laws and regulations.
This will also ensure both organizations to explore opportunities for technical cooperation in areas of mutual benefit in the development of monographs and future technologies.
It will also help adopt harmonizing standards, exchanging information on the quality of medicines, and sharing technical expertise on the development of monographs and test methods.
The areas of co-operation cover the development of standards for APIs as well as finished products. This partnership will also support exchanges of technical expertise and skill development in the subject area for the benefit of public health.
IPC is an autonomous institution of the union health ministry and has been created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for the treatment of diseases prevailing in the country.
It publishes official documents for improving the quality of medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia. It further promotes the rational use of generic medicines by publishing the National Formulary of India (NFI).
IP prescribes standards for identity, purity, and strength of drugs essentially required from the health care perspective of human beings and animals.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
